| | | |
 
  
  
  
  
  
  
  

The 11-13+6 Week Scan Theoretical Course June 1st, 2008, Vancouver Canada
Available as a pre-conference workshop at the ISPD - 14th International Conference on
Prenatal Diagnosis and Therapy

Online Registration: http://www.ispdhome.org/conference/2008/registration.asp

Description:
Official Fetal Medicine Foundation certificate course in the 11-13+6 Week Scan.

Objectives:
  • To review the current status of non-invasive genetic screening for chromosome abnormalities.
  • To ensure that those who perform the 11-13+6 week scan have received the appropriate training to do so.
  • To ensure that high standards of performance are maintained through continuing education and audit.
Audience:
Sonographers, sonologists including physicians who perform nuchal translucency ultrasound.

Course Content:
  • The principles of presnatal genetic screening and diagnosis.
  • The role of the 11-13+6 week scan in the prenatal diagnosis of chromosome and other abnormalities.
  • Combined screening using ultrasound and maternal biochemistry.
  • The guidelines for the measurement of NT.
  • Practical Demonstration.
Course Credentials:
Once successful, you will receive a certificate to acknowledge successful completion of the theoretical training of the in the "11-13+6 Week Scan Course".

Upon completion of the theoretical course, you will be eligible to register for the NT Practical Training course (Step 2 of NT credentialing, not included in this Theory course).

After attendance of the theoretical course and successful completion of the NT Practical Training course, the physician/sonographer will be sent the Certificate of Competence in the 11-13+6 weeks scan. In addition, Physicians/sonographers will be eligible to submit a registration form to the FMF for the use of the risk calculation and Quality Assurance software.

Course Directors:
Jo-Ann Johnson, MD
Division of Maternal Fetal Medicine
Department of OB/GYN
University of Calgary
Calgary, AB

Confirmed Speakers:
Jon Hyett, MD
Maternal Fetal Medicine
Royal Brisbane and Women's Hospital
Obstetrics and Gynaecology
University of Queensland

Jiri Sonek, M.D., RDMS
Dept of OB/GYN, Wright State University
Dayton, OH and Fetal Medicine Foundation USA

Cathy Downing, RDMS
Fetal Medicine Foundation USA


Preliminary Program:
8:00 Registration and Coffee
9:00 Welcome and Overview
9:10 Screening for Chromosomal Defects: An Overview
9:30 Screening for Chromosomal Defects at 11-13+6 weeks
  • Risk by maternal age and gestation
  • Risk by NT thickness
  • Risk by other 1st Trimester ultrasound markers
10:00 Break
10:15 Combined Screening: Ultrasound & Biochemistry
  • First trimester combined screening
  • First trimester sequential screening
  • Second trimester serum biochemistry
  • New biochemical markers: What is on the horizon?
11:00 Second trimester ultrasound markers: The Canadian Guidelines
11:15 Methods of obtaining the Karyotype
11:30 Putting it all together. What do the new guidelines mean for prenatal screening in Canada?
12:00 Lunch (On your own)
1:00 Abnormal biochemistry Normal Karyotype
1:15 Increased NT and a Normal Karyotype
1:30 Early Fetal Anomaly Scan
1:45 Multiple Pregnancies: Chorionicity and its Consequences-Screening in Twins
2:00 Practical Issues in NT Scanning
2:30 Certification process
2:45 Multiple choice examination
3:00 Break
3:15 Practical Demonstration
3:45 Q & A
For further information, please email info@mfmedicine.com